GLD Partners | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,763 results for “GLD Partners”

Trials

View all 3499 →

An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)

First posted Mar 25, 2010

Partners Calciphylaxis Biobank

300 participants · First posted Jan 26, 2017

Partners PrEP Program

1,381 participants · First posted Jul 13, 2018

Drugs

View all 459 →

trimethylangelicin (Rare Partners)

DLL3(Molecular Partners)

Investigational

Gatralimab

Organizations

View all 74 →

Trillium Health Partners

Canada

New Leaf Partners

United States

Partners In Health

United States

News

View all 4731 →

GLD Partners Launches Altagenics to Target Muscle-Wasting Diseases Using Advanced Functional Genomics Platform

GLD Partners Acquires Seelos Therapeutics Assets, Advancing Ketamine and Trehalose Programs to Phase 3 Trials

Spatial Lipid Mapping Reveals Psychosine Buildup Patterns in Krabbe Disease, Opening New Therapeutic Targeting Strategies

Page 1 of 877